{
  "Johnson & Johnson": {
    "2023": {
      "FORM": "8-K",
      "CATEGORIES": {
        "Section 2 - Financial Information": {
          "ITEMS": {
            "Item 2.02 - Results of Operations and Financial Condition": {
              "content": "On October 17, 2023, Johnson & Johnson issued the attached press release (Exhibit 99.1) announcing its sales and earnings for the third quarter ended October 1, 2023.",
              "subsections": {}
            }
          }
        },
        "Section 9 - Financial Statements and Exhibits": {
          "ITEMS": {
            "Item 9.01 - Financial Statements and Exhibits": {
              "content": "(d) Exhibits.",
              "subsections": {
                "Exhibit 99.1": "Press Release dated October 17, 2023 for the period ended October 1, 2023",
                "Exhibit 99.2": "Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fiscal third quarter and nine months",
                "Exhibit 104": "The cover page from this Current Report on Form 8-K, formatted in Inline XBRL."
              }
            }
          }
        }
      }
    }
  }
}